Literature DB >> 1523969

Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions.

J Zhao1, K Yoshioka, M Miyatake, T Miike.   

Abstract

To determine whether or not and how dystrophin exists in neuromuscular junctions (NMJs) and myotendinous junctions (MTJs), we studied the mid-belly and peripheral portions of control and mdx muscles, immunohistochemically and immunoelectrophoretically, using six kinds of polyclonal antibodies, and an antibody against a dystrophin-related protein (DRP). In controls these regions and the polar region of intrafusal muscle fibers showed a rather clearer immunohistochemical dystrophin reaction than those of extrafusal muscle fibers with all antibodies used. In the muscles of mdx mice NMJs only showed a positive dystrophin reaction with the c-terminal antibody, that is, no reaction with the other five antibodies, and MTJs in mdx showed a positive reaction with the c-terminal antibody and a faint to negative reaction with the other five antibodies. In biopsied human muscles NMJs and MTJs also showed a clear reaction with all ten antibodies, i.e., six polyclonal and four monoclonal ones. Although an immunohistochemical DRP reaction was clearly seen at NMJs, only a faint or no reaction was seen on MTJs and on intrafusal muscle fibers in both mouse and human materials. Western blot analysis of control mouse muscle for dystrophin showed a clearer band for the peripheral portion, which contains many MTJs, than for the mid-belly portion. These data suggest that dystrophin really exists on MTJs, and that dystrophin and DRP exist on NMJs in mouse and human muscles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523969     DOI: 10.1007/bf00311386

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Immunocytochemical study of dystrophin at the myotendinous junction.

Authors:  C E Samitt; E Bonilla
Journal:  Muscle Nerve       Date:  1990-06       Impact factor: 3.217

Review 2.  Structure and organization of the myoneural junction.

Authors:  C Coërs
Journal:  Int Rev Cytol       Date:  1967

3.  The structure of tendon organs in the cat: a proposed mechanism for responding to muscle tension.

Authors:  C F Bridgman
Journal:  Anat Rec       Date:  1968-10

4.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  Asymmetric distribution of dystrophin in developing and adult Torpedo marmorata electrocyte: evidence for its association with the acetylcholine receptor-rich membrane.

Authors:  B J Jasmin; A Cartaud; M A Ludosky; J P Changeux; J Cartaud
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Dystrophin in control and mdx retina.

Authors:  J Zhao; M Uchino; K Yoshioka; M Miyatake; T Miike
Journal:  Brain Dev       Date:  1991       Impact factor: 1.961

7.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

8.  Dystrophin: localization and presumed function.

Authors:  M Miyatake; T Miike; J E Zhao; K Yoshioka; M Uchino; G Usuku
Journal:  Muscle Nerve       Date:  1991-02       Impact factor: 3.217

9.  Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy.

Authors:  M Miyatake; T Miike; J Zhao; K Yoshioka; M Uchino; G Usuku
Journal:  J Neurol Sci       Date:  1989-10       Impact factor: 3.181

10.  Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle.

Authors:  R Sealock; M H Butler; N R Kramarcy; K X Gao; A A Murnane; K Douville; S C Froehner
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more
  9 in total

Review 1.  Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease.

Authors:  Michelle F Goody; Roger B Sher; Clarissa A Henry
Journal:  Dev Biol       Date:  2015-01-12       Impact factor: 3.582

2.  Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.

Authors:  T Kumamoto; H Ueyama; S Watanabe; K Yoshioka; T Miike; D E Goll; M Ando; T Tsuda
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 3.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

4.  In vivo dynamics of skeletal muscle Dystrophin in zebrafish embryos revealed by improved FRAP analysis.

Authors:  Fernanda Bajanca; Vinicio Gonzalez-Perez; Sean J Gillespie; Cyriaque Beley; Luis Garcia; Eric Theveneau; Richard P Sear; Simon M Hughes
Journal:  Elife       Date:  2015-10-13       Impact factor: 8.140

5.  In the human, true myocutaneous junctions of skeletal muscle fibers are limited to the face.

Authors:  Christian Albrecht May; Silvia Bramke
Journal:  J Anat       Date:  2021-02-27       Impact factor: 2.610

6.  Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration.

Authors:  Jamie L Marshall; Johan Holmberg; Eric Chou; Amber C Ocampo; Jennifer Oh; Joy Lee; Angela K Peter; Paul T Martin; Rachelle H Crosbie-Watson
Journal:  J Cell Biol       Date:  2012-06-25       Impact factor: 10.539

7.  Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.

Authors:  Hafsa Mamsa; Rachelle L Stark; Kara M Shin; Aaron M Beedle; Rachelle H Crosbie
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

8.  Sarcospan: a small protein with large potential for Duchenne muscular dystrophy.

Authors:  Jamie L Marshall; Rachelle H Crosbie-Watson
Journal:  Skelet Muscle       Date:  2013-01-03       Impact factor: 4.912

Review 9.  Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress.

Authors:  Miranda D Grounds; Jessica R Terrill; Basma A Al-Mshhdani; Marisa N Duong; Hannah G Radley-Crabb; Peter G Arthur
Journal:  Dis Model Mech       Date:  2020-03-02       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.